Monitoring the kinetics of protein interactions on a high density sensor array is vital to drug development and proteomic analysis. Label-free kinetic assays based on surface plasmon resonance are the current gold standard, but they have poor detection limits, suffer from nonspecific binding, and are not amenable to high throughput analyses. Here we show that magnetically responsive nanosensors that have been scaled to over 100,000 sensors/cm 2 can be used to measure the binding kinetics of various proteins with high spatial and temporal resolution. We present an analytical model that describes the binding of magnetically labeled antibodies to proteins that are immobilized on the sensor surface. This model is able to quantify the kinetics of antibody-antigen binding at sensitivities as low as 20 zeptomoles of solute.
molecular identities and reaction details places increasing pressure on evolving analytical methods 11, 12, 13, 14, 15, 16, 17 . To meet these pressing needs, researchers have turned to nanoscale labels in order to enhance the limit of detection (LOD) and specificity for detecting low abundance molecules. Such labels, however, can alter diffusion and steric phenomena. In addition, high-throughput, or speed requirements often prohibit the use of classical equilibrium methods, so a precise understanding of reaction kinetics, transport phenomena, and the implications of surface immobilization becomes critical for extracting meaningful molecular reaction parameters for nanoparticle labeling methodologies. This report addresses these issues and demonstrates that nanoparticle labeled proteins offer unique advantages over label-free methods, making this system very effective for modeling and extracting binding kinetics and analyte transport.
Extant modeling of molecular interactions has predominantly been restricted to label-free binding in solution. Early work by Berg and Stenberg proposed some of the first kinetic models of surface antigen-antibody interactions that explained the new restrictions that labeled reagents introduce on surface reaction kinetics by altering rotational and translational motion 18, 19, 20 . Furthermore, they argued that the use of targets immobilized on sensor surfaces implies that diffusion can become problematic due to the existence of long range concentration gradients, which can require ligands to traverse macroscopic distances (>100 μm) prior to reaction. Though many of these details are elaborated by Waite 21 and Sheehan 22 , their emphasis on numerical methods precludes the derivation of semi-analytical expressions. While binding kinetics of quantum-dot-labeled macromolecules in liquid phase has been studied with fluorescence cross-correlation spectroscopy 23, 24 , we found no similar literature describing reactions on a sensor surface. Our investigation provides new quantitative insight into the binding kinetics of labeled macromolecules interacting with targets immobilized on a sensor surface, addressing this gap in the literature.
GMR nanosensor platform and magnetic nanoparticle tags
Our approach utilizes giant magnetoresistive (GMR) biosensors, an emerging tool for both basic science research and clinical diagnostics. Their superior LOD, multiplex capacity, broad linear dynamic range, and real-time readout capabilities make them ideal for kinetic analysis measurements 25, 26, 27 . GMR nanosensors, initially utilized as read head elements in computer hard drives, operate by changing their electrical resistance in response to changes in the local magnetic field 28, 29, 30, 31 . Recent work has adapted GMR sensors for detection of biological species in solution by implementing a traditional sandwich assay directly on GMR nanosensors. If a magnetic particle is introduced to label the biomolecule of interest, GMR sensors are capable of highly sensitive DNA and protein detection 32, 33, 34, 35, 36 . This prior work 25, 26 has involved quantifying the amount of protein, but has provided little information about the kinetics of the biomolecular reaction. In the current research, we prelabel the soluble ligand with a magnetic nanoparticle (MNP) in order to monitor the realtime binding kinetics of the ligand-MNP complex to antigens immobilized on sensor surfaces (Fig. 1a) . As the antibody-MNP complexes are captured, their magnetic fields induce changes in electrical resistance in the underlying GMR sensor. Using the rapid, realtime readout of our GMR sensor array 25 , we can monitor and quantify the kinetics of binding, thus determining the associated kinetic rate constants. Each GMR sensor in the array covers a total area of 100 μm × 100 μm and is comprised of twelve parallel GMR sensor stripes that are connected in series six times, producing a total of 72 stripes per sensor (Fig. 1b) . Each stripe is 750 nm wide, approximately 20 nm thick, and spans 100 μm in length. Using scanning electron microscopy, it is possible to resolve nanoparticles bound over each sensor stripe (Fig. 1b insert) .
The MNPs that label the protein or antibody of interest are comprised of approximately twelve 10 nm iron oxide cores embedded in a dextran polymer (Fig. 1c) , as determined by TEM analysis 37 . The entire nanoparticle averages 46 ± 13 nm in diameter (from number weighted Dynamic Light Scattering). Based on the Stokes-Einstein relation, these particles have a translational diffusion coefficient of approximately 9.3×10 -12 m 2 s -1 . The MNPs have a reported zeta potential of -11 mV 38 . These particles are superparamagnetic and colloidally stable, so they do not aggregate or precipitate during the reaction. Importantly, the GMR sensors operate as proximity-based detectors of the dipole fields from the magnetic tags; thus, only tags within ∼150 nm of the sensor surface are detected 25 . Therefore, unbound MNP tags contribute negligible signal in the absence of binding, making this unique nanosensor-MNP system ideal for real-time analysis of kinetic binding process at the sensor surface.
Our GMR assay using MNP labels has several advantages over surface plasmon resonance (SPR) -the standard method of monitoring protein binding interactions, which operates by measuring changes in the refractive index of a thin film when unlabeled solute molecules bind to the surface 39, 40 . While recent studies have attempted to design higher density SPR instrumentation 41, 42, 43 , their methods typically monitor only a few reactions in parallel, and their LOD and dynamic range are limited to ∼ 25 ng mL -1 and ∼ 2 logs, respectively. In contrast, the GMR biosensor array can simultaneously monitor hundreds to thousands of sensors at sensitivities of ∼ 1 pg mL -1 or below and dynamic ranges of 6 logs or more 26 . Furthermore, we have fabricated GMR sensor arrays with 1,008 sensors on a 1 mm 2 chip area 44 . The calculated feature density is now over 100,000 GMR sensors per cm 2 , the highest density reported to date for biosensor technologies. Each sensor within a sub-array is individually addressable by row and column decoders via a shared 6-bit control bus fabricated with state of the art VLSI technology. Such highly integrated GMR sensor arrays allow for exceptionally sensitive, massively parallel multiplex monitoring of protein binding kinetics.
Mathematical model of binding kinetics
Given our ability to monitor real-time binding kinetics using highly sensitive and multiplexed nanosensors, we first tested the widely used Langmuir absorption isotherm model, which assumes that there is negligible depletion of reactants and that the concentration of reactants near the surface is the same as that in the bulk. However, this did not adequately describe the binding kinetics in our system ( Supplementary Fig. 1 ). A new model that would accurately describe the binding rates and would give an analytical solution is needed to explicitly describe the microscopic processes and offer insights into the mechanism of the overall reaction. We devised an analytical model capable of fitting the data with a high degree of generality across a variety of reaction conditions. This new model is capable of fitting real-time binding kinetics data for nanoparticle labeled macromolecules so that one can calculate the molecular association and dissociation rate constants, k on and k off .
Traditionally, protein binding is envisioned as a two-step process in which the target protein or antibody in the bulk solution first enters a surface compartment (reaction zone) via diffusion and flow, and then binds to or escapes from the immobilized targets via the chemical processes of association and dissociation ( Supplementary Fig. 2 ) 45 . If the soluble ligand diffuses slowly, as for a large MNP tag, the diffusion into the reaction zone becomes negligible (see materials and methods and Supplementary Figs. 2-3 for complete derivation). Therefore, replenishment of soluble antibody-MNP via diffusion from the bulk compartment (bulk zone) to the surface compartment can be assumed to be zero in our model. Accordingly, the rate equation for the traditional two-compartment model can be reduced to the following (see materials and methods for derivation): (1) where n is the surface concentration of bound MNP-antibody-antigen complexes that have formed over the sensor, k on is the association rate constant, k off is the dissociation rate constant, C 0 is the bulk concentration of magnetically tagged antibody, n max is the maximum moles of surface bound complexes per area, V is the volume of the surface compartment and A is the reaction area (in this case it refers to the surface area of each sensor). The quantity of nA/V is equivalent to the bulk concentration in the reaction zone which would be consumed to produce the surface concentration, n, according to mass conservation. Conceptually, the two terms within the parentheses represent the depletion of tagged antibody in the reaction zone and reduction of available surface sites due to binding, respectively.
As both volume and surface concentrations are discussed, we must be aware of the different dimensions: n and n max are expressed in mol m -2 whereas C s and C 0 are expressed in mol m -3 . Note that n max is limited by the maximum concentration of close packed MNPs, not by the maximum concentration of analyte on the surface. Therefore, in order to exclude steric effects related to MNP crowding on the sensor surfaces, the highest analyte surface concentration tested was significantly lower than the surface concentration of the close packed antibody-MNP complexes. In addition, by restricting the amount of protein deposited on the sensor surface to be under this limit, the proteins will be spaced across the sensor at distances greater than one MNP diameter. Therefore, each binding event monitored will be from one antibody on a MNP binding to one antigen on the sensor, and not from multiple antibodies binding to multiple antigens, mitigating avidity issues that may complicate the model.
We further simplify Equation 1 by assuming that k off is zero, since antibody-antigen dissociation is typically negligible on the 400-1,000 second time scales of our experiments (Supplemental Fig. 3 ). Equation 1 now has the following analytical solution (derivation in online materials and methods): (2) If C 0 V ≫ n max A, which implies a vast excess of solution molecules over available surface sites, the kinetics reduce to Langmuir absorption dynamics (derivation in online materials and methods), demonstrating that the Langmuir model is merely a special case of our more general analytical model.
Experimental and theoretical binding kinetics measurements
To test this solution, we examined antibody-antigen binding kinetics for epithelial cell adhesion molecule (EpCAM) using this analytical model, and compared our experimental results to literature values. Anti-EpCAM antibody was selected because it was formulated into a chemotherapeutic drug, edrecolomab 46 .
In the first set of binding experiments, presented in Figure 2a , we performed a binding assay of MNP-labeled anti-EpCAM antibody to surface-bound EpCAM protein. C 0 , n max , V, and A in the model were fixed values determined from dimensions and concentrations, and k on was determined via best fit of the predicted binding curves to experimental data. We first performed a binding assay for varying concentrations of surface bound EpCAM protein at a fixed concentration of MNP-anti-EpCAM antibody complexes. Twofold dilutions were used to prepare a series of sensor surfaces, beginning at a loading mass (i.e., the amount of protein that is actually bound to the sensor surface and functional) of 5 attomoles of EpCAM and diluting sequentially down to 20 zeptomoles. Therefore, the only parameter that varied between binding curves was n max ; all other parameters were unchanged. When this one parameter variation is implemented in the model, each experimental binding curve was fitted accurately (Fig. 2a) . The values of the parameters (the undiluted case) were n max = 9.5 × 10 -10 mol m -2 , C 0 = 6.8 × 10 -7 M, A = 5.4 × 10 -9 m 2 and V = 5.5 × 10 -12 m 3 . Accordingly, k on = 2.5 × 10 4 M -1 s -1 fit the data best (R 2 = 0.98). In addition, after the MNP-antibody solution was washed away and replaced by antigen-loaded buffer, dissociation constants were calculated by fitting the subsequent data to a basic exponential decay model, n Release (t) = n 0 e −k off t , where n 0 is the surface concentration of bound MNPs at the time of washing (derivation in online materials and methods). Accordingly, the anti-EpCAM antibodyantigen dissociation constant, k off , was determined to be 2.0 × 10 -6 s -1 , supporting our assumption that k off is essentially negligible compared to k on .
In a second set of binding experiments, presented in Figure 2b , each sensor was immobilized with a constant load mass of 833 zeptomoles of EpCAM protein (1/6 of the maximum amount used in Figure 2a) . The concentration of antibody-MNP complex applied to the sensors was varied between undiluted, twofold diluted, and eightfold diluted solutions of antibody-MNP complexes (corresponding to C 0 , C 0 /2 and C 0 /8 in the model). Since the antibody-antigen interaction should remain the same whether C 0 or n max is altered, the rate constants describing the interaction above should remain the same across these diverse experiments, as was observed. In fitting the model, we obtained the same k on of 2.5 × 10 4 M -1 s -1 (R 2 =0.96), supporting the validity of our analytical model. Furthermore, these results lie within the expected range reported in the literature, confirming both the validity of our kinetic model to predict binding and the accuracy of the results derived (Table 1) .
Similar real-time experiments were performed in order to quantify binding kinetics for MNP-anti-carcinoembryonic antigen (CEA) antibody to CEA, MNP-anti-vascular endothelial growth factor (VEGF) antibody to VEGF, and MNP-streptavidin to biotin binding kinetics ( Supplementary Fig. 4 ). CEA and VEGF were chosen because they are among the most well-known clinical tumor markers, and anti-VEGF antibody drugs, such as bevacizumab (Avastin; Genentech/Roche), are highly effective anti-cancer drugs 46, 47 . For anti-CEA antibody, binding and dissociation constants were monitored with the same reagents on both GMR sensors and SPR instruments, and the results were compared (Supplementary Figs. 4c,d) . The GMR sensor array and SPR measurements yielded kinetic constants that were consistent with one another and with literature values (Table 1) .
Scanning electron microscopy (SEM) confirmed that our analytical system also has the ability to quantify the precise number of proteins captured on each sensor. Thus, by calibrating GMR signal to an absolute number of magnetic tags bound to the sensor surface, we can derive the mass of protein bound and the signal generated per MNP. To accomplish this, a combination of the prior two experiments was performed and accurately modeled where EpCAM protein was serially diluted in twofold increments, starting at 2.5 attomoles and ending at 78 zeptomoles, on three to eight replica sensors (Fig. 3 left panel) . A 20-fold dilution of the MNP-antibody complexes was subsequently added to all the sensors and the binding kinetics were monitored. After 20 minutes of incubation time, the solution of magnetically labeled antibody was washed away to terminate the binding reaction, at which point the sensors were imaged by SEM (Fig. 3 right panel) . By normalizing the real-time experimental data and fitting it to the model, we were able to convert the sensor signal, measured as a change in magnetoresistance (MR) normalized to the initial MR (ΔMR/MR 0 ), into the number of magnetic tags bound to each sensor. For example, the sensor functionalized with 2.5 attomoles of EpCAM protein captured 190,000 MNP tags within the time of the experiment. SEM imaging reveals that experimental results match with predictions from the kinetic model, thus extending the validity of the model for precisely quantifying the number of tags bound per sensor and determining the number of proteins that bind during a given reaction.
Furthermore, using our models, we estimate that every 150 MNPs produce ∼1 ppm of the normalized signal. The LOD of our sensors is ∼20 ppm (defined by the average background signal of a non-complementary antibody coated sensor plus two standard deviations). Therefore, we can detect as few as 0.6 particles μm -2 . In addition, the model is capable of explaining when saturation of the sensor surface will occur. For example, when 10 attomoles of protein are deposited on the sensor surface, experimental data shows that the sensor surface is approaching saturation as judged by comparing signals at 5 attomoles and lower ( Supplementary Fig. 5) . A loading mass of 10 attomoles is described in the model as n max being equal to 1.9×10 -9 mol m -2 . The saturation value predicted by the model is thus in close agreement with the maximum surface concentration of the MNPs in a close packed single layer, 1.0 × 10 -9 mol m -2 .
Our real-time binding assay and kinetic model has been extended to visualize protein binding events in both space (due to the high density of the array architecture) and time (due to the rapid and real-time readout). As an example, we first immobilized the same anti-CEA capture antibody across a sensor array. We then added MNP-anti CEA conjugates in solution to the sensor well. Upon delivery of the CEA antigen, we were able to monitor the movement of CEA protein across the sensor array (Fig. 4a) . With this method, we can visualize the binding of soluble CEA protein to each sensor, which is spatially distributed in the array, by means of the MNP-anti-CEA antibody binding (Fig. 4b and Supplementary  Fig. 6 ). In this manner, each sensor monitors the reaction zone above it, and thus we can investigate protein binding, protein transport, and protein dynamics with high spatial and temporal resolution--an important and unique development. Such techniques will be applied to monitor localized cell-cell communications via cellular protein secretome analysis in future works.
Discussion and conclusions
We have presented a high-density, highly sensitive, real-time binding assay for quantifying protein binding kinetics and analyte transport at the surface of a biosensor array. Notably, we have also developed a novel analytical kinetics model that provides a precise and physically intuitive description of the dominant processes involved in labeled proteinprotein interactions. We proved that the reduced rate of diffusion, that is consistent with the addition of nano-scale labels, can be exploited to derive generalizable kinetic binding models with analytical solutions. The combination of the GMR sensor technology and analytical model has enabled us to measure protein binding constants and quantify the number of proteins bound to a given sensor with unprecedented LOD. Furthermore, we have demonstrated the unique benefits of combining our GMR sensor array, kinetic binding assay, and analytical model to visualize protein transport in a reaction well.
The tools we have developed can be used broadly in basic science research for understanding receptor-ligand binding interactions involved in signal transduction in cell biology or for profiling the affinity of specific compounds of interest against an entire proteome on a high density array. In addition, applications to pharmacodynamics via receptor occupancy assays for drug development would open an entirely new and broad segment for our technology. MHC-peptide and T-cell receptor interactions could also be studied with exceptional speed and accuracy.
Further, the potential clinical applications of our method are vast, ranging from in-vitro clinical assay development 52 , to targeted molecular imaging for early cancer diagnostics 53 , to investigating drug on-target and off-target cross-reaction 54 binding kinetics. In each case, the affinity and cross-reactivity of reagents and targeting probes are critical issues to clinical adoption and can be easily addressed with our platform. In short, our method represents a significant advance in this domain as it has the potential to provide fundamentally important solutions for both cutting-edge basic science research and clinical practice.
Materials and Methods

GMR nanosensor array architecture
The giant magnetoresistive (GMR) sensor used in our experiment has a bottom spin valve structure of the type: Si/Ta(5)/seed layer/IrMn(8)/CoFe(2)/Ru/(0.8)/CoFe(2)/Cu(2.3)/ CoFe(1.5)/Ta(3), all numbers in parenthesis are in nanometers. Each chip contains an array of GMR sensors, which are connected to peripheral bonding pads by a 300 nm thick Ta/Au/Ta lead. To protect the sensors and leads from corrosion, two passivation layers were deposited by ion beam sputtering: first, a thin passivation layer of SiO 2 (10 nm)/Si 3 N 4 (20 nm)/ SiO 2 (10nm) was deposited above all sensors and leads, excluding only the bonding pad area; then a thick passivation layer of SiO 2 (100 nm)/Si 3 N 4 (150 nm)/SiO 2 (100 nm) was deposited on top of the reference sensors and leads, but excluding the active sensors and bonding pad area. The magnetoresistive ratio is approximately 12% after patterning. The pinning direction of the spin valve is in-plane and perpendicular to the sensor strip. The easy axis of the free layer is set by the shape anisotropy to be parallel with the sensor strip. This configuration allows the GMR sensors to work at the most sensitive region of their MR transfer curves.
Due to the GMR effect, the resistance of the sensor changes with the orientation of the magnetization of the two magnetic layers, which are separated by a copper spacer layer: (3) Here R 0 is the resistance under zero magnetic field, δR max is the maximum resistance change and θ is the angle between the magnetization of the two magnetic layers. In the bottom spin valve structure, the magnetization of the bottom magnetic layer (pinned layer) is pinned to a fixed direction, while the magnetic orientation of the top magnetic layer (free layer) can freely rotate with the external magnetic field. As a result, the stray field from magnetic labels can change the orientation of the free layer magnetization and therefore change the resistance of the sensor.
Magnetic labels
The magnetic labels we used are commercial magnetic nanoparticles from Miltenyi Biotech Inc., referred to as "MACS". Each MACS particle is a cluster of 10nm Fe 2 O 3 nanoparticles held together by a matrix of dextran. Due to the small size of the Fe 2 O 3 nanoparticles, the MACS particle is superparamagnetic, with a hydrodynamic diameter of ∼46 nm, and contains ∼10% magnetic material (wt/wt). MACS particles can be functionalized with specific affinity molecules corresponding to the analyte being studied. For EpCAM (CEA, VEGF) experiments, the MACS particles are functionalized with anti-EpCAM (CEA, VEGF) antibodies; for biotin-streptavidin experiments, the MACS particles are functionalized with streptavidin.
Surface chemistry
The sensor surface was first cleaned using acetone, methanol and isopropanol and subsequently exposed to oxygen plasma for three minutes. A 2% (w/v) polyallylamine solution in Milli-Q water was applied to the sensor for 5 minutes. The chips were then rinsed with Milli-Q water and baked at 150°C for 45 minutes. A 10% (w/v) solution of EDC and 10% (w/v) solution of NHS were then added to the sensor surface at room temperature for 1 hour, after which the sensor was rinsed and dried. Capture protein EpCAM (960-EP-050 from R&D Systems), CEA (4128-CM-050 from RD Systems) or VEGF (293-VE165 from R&D Systems) or capture antibody (antibody to EpCAM (ab20160 from Abcam or 960 from R&D), CEA (5910 from BiosPacific) or VEGF (ab69479 from Abcam) was robotically deposited (Scienion sciFlexarrayer from BioDot) over each sensor in 360 picoliter droplets 3 times (total volume of ∼1 nanoliter). In order to monitor reproducibility, from 3 to 8 sensors, randomly distributed across the GMR sensor array, were incubated with the same capture protein. The control sensors were immobilized in a similar fashion with either BSA at 1 mg/mL or a non-complementary antibody (typically anti-survivin antibody (H00000332-P01 from Novus Biologicals, LLC) at 500 μg/mL. Finally, the entire surface of the sensor array was blocked with 1 mg/mL of BSA in phosphate buffered saline for 30 minutes.
Kinetic Assay
After the sensor surface is functionalized with the appropriate capture protein, the GMR sensor array was placed in the test station. The BSA blocking buffer was washed away and a 50 μL solution of the magnetically labeled detection antibody (described above) was added to the reaction well. The GMR sensor array was monitored in real-time as the magnetically labeled detection antibodies bound to the corresponding surface-immobilized proteins. The binding curves, unique to each protein, were then plotted and the binding constants could be determined. An assay is typically run for approximately 5 minutes.
Supplementary Material
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